Inappin
Inappin Brand names, Inappin Analogs
Inappin Brand Names Mixture
- No information avaliable
Inappin Chemical_Formula
C10H16NO+
Inappin RX_link
http://www.rxlist.com/cgi/generic3/edrophonium.htm
Inappin fda sheet
Inappin msds (material safety sheet)
Inappin Synthesis Reference
No information avaliable
Inappin Molecular Weight
166.24 g/mol
Inappin Melting Point
No information avaliable
Inappin H2O Solubility
Appreciable as liquid hydrochloride salt
Inappin State
Liquid
Inappin LogP
-2.95
Inappin Dosage Forms
Liquid for injection
Inappin Indication
For the differential diagnosis of myasthenia gravis and as an adjunct in the evaluation of treatment requirements in this disease. It may also be used for evaluating emergency treatment in myasthenic crises.
Inappin Pharmacology
Edrophonium is a short and rapid-acting anticholinesterase drug. Its effect is manifest within 30 to 60 seconds after injection and lasts an average of 10 minutes. Edrophonium's pharmacologic action is due primarily to the inhibition or inactivation of acetylcholinesterase at sites of cholinergic transmission. Muscarinic receptors are found throughout the body, especially on muscle. Stimulation of these receptors causes to muscle contraction. In myasthenia gravis the body's immune system destroys many of the muscarinic receptors, so that the muscle becomes less responsive to nervous stimulation. Edrophonium chloride increases the amount of acetylcholine at the nerve endings. Increased levels of acetyl choline allow the remaining receptors to function more efficiently.
Inappin Absorption
Rapidly absorbed.
Inappin side effects and Toxicity
With drugs of this type, muscarine-like symptoms (nausea, vomiting, diarrhea, sweating, increased bronchial and salivary secretions and bradycardia) often appear with overdosage (cholinergic crisis).
Inappin Patient Information
No information avaliable
Inappin Organisms Affected
Humans and other mammals
